Spot The Pattern & Treat The Cancer

Freenome is a biotechnology company on a mission to empower everyone with the tools they need to detect, treat, and ultimately prevent their diseases.

By applying advanced machine learning techniques to recent breakthroughs in genomic science, Freenome is developing simple blood tests to detect early-stage cancer and make treatments more effective. The company has raised $238 million from investors such as RA Capital, Polaris Partners, Perceptive Advisors, Andreessen Horowitz, funds and accounts advised by T. Rowe Price Associates, Inc., GV (formerly Google Ventures), Roche Venture Fund, Kaiser Permanente Ventures, American Cancer Society’s BrightEdge Ventures, Data Collective Venture Capital, and Verily Life Sciences (formerly Google Life Sciences).

United States United States
259 East Grand Avenue Suite 3434 , San Francisco, California 94080
$50 - $99/hr
50 - 249
2014

Service Focus

Focus of Artificial Intelligence
  • Deep Learning - 50%
  • Machine Learning - 50%

Industry Focus

  • Healthcare & Medical - 100%

Client Focus

70% Small Business
30% Medium Business

Detailed Reviews of Freenome

No Review
No reviews submitted yet.
Be the first one to review
This profile is not claimed

Do you own or represent this business? Enter your business email to claim your GoodFirms profile.

Thank you for claimed

You have successfully submit request your claim